76 related articles for article (PubMed ID: 12168662)
1. Recombinant human bone morphogenetic protein-4 (rhBMP-4) enhanced posterior spinal fusion without decortication.
Guo X; Lee KM; Law LP; Chow HK; Rosier R; Cheng CY
J Orthop Res; 2002 Jul; 20(4):740-6. PubMed ID: 12168662
[TBL] [Abstract][Full Text] [Related]
2. rhBMP-6 stimulated osteoprogenitor cells enhance posterolateral spinal fusion in the New Zealand white rabbit.
Valdes M; Moore DC; Palumbo M; Lucas PR; Robertson A; Appel J; Ehrlich MG; Keeping HS
Spine J; 2007; 7(3):318-25. PubMed ID: 17482115
[TBL] [Abstract][Full Text] [Related]
3. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion.
Akamaru T; Suh D; Boden SD; Kim HS; Minamide A; Louis-Ugbo J
Spine (Phila Pa 1976); 2003 Mar; 28(5):429-34. PubMed ID: 12616152
[TBL] [Abstract][Full Text] [Related]
4. rhBMP-2 enhancement of posterolateral spinal fusion in a rabbit model in the presence of concurrently administered doxorubicin.
Singh K; Smucker JD; Ugbo JL; Tortolani PJ; Tsai L; Fei Q; Kuh S; Rumi M; Heller JG; Boden SD; Yoon ST
Spine J; 2007; 7(3):326-31. PubMed ID: 17482116
[TBL] [Abstract][Full Text] [Related]
5. Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model.
Fischgrund JS; James SB; Chabot MC; Hankin R; Herkowitz HN; Wozney JM; Shirkhoda A
J Spinal Disord; 1997 Dec; 10(6):467-72. PubMed ID: 9438810
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of fusion rate induced by different dosages of Escherichia coli-derived recombinant human bone morphogenetic protein-2 using hydroxyapatite carrier.
Lee JH; Yu CH; Yang JJ; Baek HR; Lee KM; Koo TY; Chang BS; Lee CK
Spine J; 2012 Mar; 12(3):239-48. PubMed ID: 22341396
[TBL] [Abstract][Full Text] [Related]
7. A porcine collagen-derived matrix as a carrier for recombinant human bone morphogenetic protein-2 enhances spinal fusion in rats.
Miyazaki M; Morishita Y; He W; Hu M; Sintuu C; Hymanson HJ; Falakassa J; Tsumura H; Wang JC
Spine J; 2009; 9(1):22-30. PubMed ID: 18805060
[TBL] [Abstract][Full Text] [Related]
8. The effect of platelet-rich plasma and bone marrow on murine posterolateral lumbar spine arthrodesis with bone morphogenetic protein.
Rao RD; Gourab K; Bagaria VB; Shidham VB; Metkar U; Cooley BC
J Bone Joint Surg Am; 2009 May; 91(5):1199-206. PubMed ID: 19411469
[TBL] [Abstract][Full Text] [Related]
9. Enhancing effects of a prostaglandin EP4 receptor agonist on recombinant human bone morphogenetic protein-2 mediated spine fusion in a rabbit model.
Namikawa T; Terai H; Hoshino M; Kato M; Toyoda H; Yano K; Nakamura H; Takaoka K
Spine (Phila Pa 1976); 2007 Oct; 32(21):2294-9. PubMed ID: 17906568
[TBL] [Abstract][Full Text] [Related]
10. [Bone inductive effects of rhBMP-2 loaded porous CPC implants on spine fusion in rabbits].
Zhong R; Fei Q; Zhang J; Chen T; Liu C; Long Z; Yu R; Huang H
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Feb; 23(2):231-4. PubMed ID: 19275111
[TBL] [Abstract][Full Text] [Related]
11. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
[TBL] [Abstract][Full Text] [Related]
12. How does recombinant human bone morphogenetic protein-4 enhance posterior spinal fusion?
Cheng JC; Guo X; Law LP; Lee KM; Chow DH; Rosier R
Spine (Phila Pa 1976); 2002 Mar; 27(5):467-74. PubMed ID: 11880831
[TBL] [Abstract][Full Text] [Related]
13. The adjunctive effect of a binding peptide on bone morphogenetic protein enhanced bone healing in a rodent model of spinal fusion.
Alanay A; Chen C; Lee S; Murray SS; Brochmann EJ; Miyazaki M; Napoli A; Wang JC
Spine (Phila Pa 1976); 2008 Jul; 33(16):1709-13. PubMed ID: 18580546
[TBL] [Abstract][Full Text] [Related]
14. Use of recombinant human bone morphogenetic protein-2 to enhance posterior cervical spine fusion at 2 years of age: technical note.
Oluigbo CO; Solanki GA
Pediatr Neurosurg; 2008; 44(5):393-6. PubMed ID: 18703886
[TBL] [Abstract][Full Text] [Related]
15. Biomimetic calcium phosphate coatings as bone morphogenetic protein delivery systems in spinal fusion.
Majid K; Tseng MD; Baker KC; Reyes-Trocchia A; Herkowitz HN
Spine J; 2011 Jun; 11(6):560-7. PubMed ID: 20097616
[TBL] [Abstract][Full Text] [Related]
16. Posterolateral lumbar spine fusion with INFUSE bone graft.
Glassman SD; Carreon L; Djurasovic M; Campbell MJ; Puno RM; Johnson JR; Dimar JR
Spine J; 2007; 7(1):44-9. PubMed ID: 17197332
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic protein-2 enhances bone formation when delivered by a synthetic matrix containing hydroxyapatite/tricalciumphosphate.
Jung RE; Weber FE; Thoma DS; Ehrbar M; Cochran DL; Hämmerle CH
Clin Oral Implants Res; 2008 Feb; 19(2):188-95. PubMed ID: 18067602
[TBL] [Abstract][Full Text] [Related]
18. The in vivo biological effects of intradiscal recombinant human bone morphogenetic protein-2 on the injured intervertebral disc: an animal experiment.
Huang KY; Yan JJ; Hsieh CC; Chang MS; Lin RM
Spine (Phila Pa 1976); 2007 May; 32(11):1174-80. PubMed ID: 17495773
[TBL] [Abstract][Full Text] [Related]
19. ISSLS prize winner: positron emission tomography and magnetic resonance imaging for monitoring interbody fusion with equine bone protein extract, recombinant human bone morphogenetic protein-2, and autograft.
Foldager C; Bendtsen M; Zou X; Zou L; Olsen AK; Munk OL; Stødkilde-Jørgensen H; Bünger C
Spine (Phila Pa 1976); 2008 Dec; 33(25):2683-90. PubMed ID: 19002076
[TBL] [Abstract][Full Text] [Related]
20. rhBMP-2 (ACS and CRM formulations) overcomes pseudarthrosis in a New Zealand white rabbit posterolateral fusion model.
Lawrence JP; Waked W; Gillon TJ; White AP; Spock CR; Biswas D; Rosenberger P; Troiano N; Albert TJ; Grauer JN
Spine (Phila Pa 1976); 2007 May; 32(11):1206-13. PubMed ID: 17495777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
